Insitro
Founded in 2018, Insitro is a data-driven drug discovery and development company headquartered in San Francisco. The company has raised $743 million after a Series C round that pulled in a massive $400 million in March 2021, drawing investments from the likes of Andreessen Horowitz and the Canada Pension Plan Investment Board. Insitro was founded by Dr. Daphne Koller, a professor of computer science at Stanford University, recipient of the MacArthur Fellowship (also known as the Genius Grant), and co-founder of Coursera alongside Andrew Ng. We talked about Insitro landing a three-year deal with Gilead (GILD) back in 2019.
Last updated on
About Insitro
Founded
2018Estimated Revenue
$1M-$10MEmployees
251-1KFunding / Mkt. Cap
$743MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
54Location
City
South San FranciscoState
CaliforniaCountry
United StatesInsitro
Find your buyer within Insitro